GEN Exclusives

More »

The Lists

More »
Jul 14, 2014

Top 20 R&D Spenders among Tool and Tech Companies

Consistent delivery of powerful innovations requires significant investment. These firms are all in.

Top 20 R&D Spenders among Tool and Tech Companies

Find out who spent the most on developing the tools you use in the lab. [© Orlando Florin Rosu - Fotolia.com]

  • The market of life science tools and technology providers has undergone only a few changes since the last time GEN published this list more than a year ago. Some of the major driving factors for the growth of the life sciences tools market include rising demand from various research and pharmaceutical companies, the increasing incidence of new and drug-resistant diseases, and technological advancement in the various life science fields, according to a report from Transparency Market Research.

    But the changes to this year’s GEN listing are huge: Life Technologies has been acquired by Thermo Fisher Scientific for $13.6 billion, plus $1.5 billion in debt, in a deal completed February 2 of this year, while Complete Genomics’ $117.6 million acquisition by BGI Shenzhen was completed on March 18, 2013.

    As a result, Life Tech and Complete Genomics aren’t within this year’s list of top 20 life sciences tools and technologies providers—a list that includes both companies and divisions of broader corporate giants as ranked by their R&D spending for 2012.

    Listings include R&D spending for 2012 and 2011, the percentage difference between the two years, the percentage of sales for both years, and 2008 R&D spending and percentage of sales.

  • #20. Eppendorf International

    2013 R&D spending: $38.4 million (€28.2 million)1

    2012 R&D spending: $37.4 million (€27.5 million)1

    % Change: 2.5%

  • #19. Sequenom

    2013 R&D spending: $46.532 million

    2012 R&D spending: $50.525 million2

    % Change: -7.9%

  • #18. Affymetrix

    2013 R&D spending: $47.670 million

    2012 R&D spending: $57.881 million

    % Change: -17.6%

  • #17. Sartorius Stedim Biotech

    2013 R&D spending: $48.981 million (€35.998 million)

    2012 R&D spending: $43.236 million (€31.776 million)3

    % Change: 13.3%

  • #16. Sigma-Aldrich

    2013 R&D spending: $66 million

    2012 R&D spending: $69 million

    % Change: -4.3%

  • #15. Cepheid

    2013 R&D spending: $80.197 million

    2012 R&D spending: $71.673 million

    % Change: 11.9%

  • #14. Waters

    2013 R&D spending: $100.536 million

    2012 R&D spending: $96.004 million

    % Change: 4.7%

  • #13. Mettler-Toledo International

    2013 R&D spending: $116.346 million

    2012 R&D spending: $112.530 million

    % Change: 3.4%

  • #12. PerkinElmer

    2013 R&D spending: $133.023 million

    2012 R&D spending: $132.639 million

    % Change: 0.3%

  • #11. Qiagen

    2013 R&D spending: $146.070 million

    2012 R&D spending: $122.476 million

    % Change: 19.3%


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?